Page last updated: 2024-09-02

ta 0910 and Autosomal Dominant Cerebellar Ataxia, Type II

ta 0910 has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Honda, M; Kimura, S; Nakamura, T; Oda, S; Ono, H; Tanabe, M	1

Other Studies

1 other study(ies) available for ta 0910 and Autosomal Dominant Cerebellar Ataxia, Type II

Article	Year
Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy. Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:12 Topics: Animals; Ataxia; Biogenic Monoamines; Brain Stem; Cerebellum; Disease Models, Animal; Drug Administration Schedule; Mice; Mice, Neurologic Mutants; Nootropic Agents; Spinal Cord; Spinocerebellar Ataxias; Thyrotropin-Releasing Hormone	2005

Article

Year

Taltirelin improves motor ataxia independently of monoamine levels in rolling mouse nagoya, a model of spinocerebellar atrophy.

Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:12

Topics: Animals; Ataxia; Biogenic Monoamines; Brain Stem; Cerebellum; Disease Models, Animal; Drug Administration Schedule; Mice; Mice, Neurologic Mutants; Nootropic Agents; Spinal Cord; Spinocerebellar Ataxias; Thyrotropin-Releasing Hormone

2005